Coping with COVID: FDA authorization pending for use of Pfizer COVID-19 vaccine on ages 12 to 15

Pfizer has requested emergency use authorization from the Food and Drug Administration to allow use of its COVID-19 vaccine on those aged 12 to 15. The pharmaceutical corporation anticipates approval as soon as this week. If granted, vaccines will start being administered by the end of the month.

The Food and Drug Administration (FDA) is expected to approve the emergency use of the Pfizer COVID-19 vaccine for ages 12-15, possibly by the end of the week.

This would mean all high schoolers and even most middle schoolers would be able to get the Pfizer vaccine.

Pfizer said that clinical trials showed the vaccine was 100 percent effective in 12- to 15-year-olds who have normal immune systems.

If authorized this week, this young age group may start receiving the Pfizer later this month.